PART 2 | Establishment of MediShield Life Scheme |
| 3.—(1) A medical insurance scheme, known as the MediShield Life Scheme, is established for the purpose of paying the whole or part of the costs incurred by an insured person for any approved medical treatment or services that is a claimable medical treatment or services received by the insured person from an approved medical institution during the period when the insured person is insured under the Scheme. [Act 40 of 2024 wef 01/04/2025] | (2) The Board is to administer the Scheme in accordance with this Act. |
| (3) The Scheme applies to every person who is a citizen or permanent resident of Singapore. |
|
| Approval of medical institution in respect of approved medical treatment or services |
3A.—(1) A medical institution may apply to the Minister, in any form and manner that the Minister requires, to be approved in respect of any approved medical treatment or services.(2) Upon receiving an application under subsection (1), the Minister may —| (a) | approve the medical institution in respect of any approved medical treatment or services that is or is part of a licensable healthcare service that the medical institution is licensed to provide under the Healthcare Services Act 2020, subject to any conditions that the Minister thinks fit, including conditions specifying the service delivery mode by which the medical treatment or services is to be provided; or | | (b) | refuse to grant the approval. |
|
| (3) In addition, the Minister may grant the approval mentioned in subsection (2)(a) on the Minister’s own initiative. |
(4) To avoid doubt, where —| (a) | a medical institution is licensed under the Healthcare Services Act 2020 to provide 2 or more licensable healthcare services (whether each of the same or a different type); and | | (b) | the medical institution provides one or more approved medical treatments or services as part of each licensable healthcare service, |
| then, under subsection (2)(a) or (3) — |
| (c) | the Minister may, in respect of a licensable healthcare service, approve the medical institution for one or more of the approved medical treatments or services provided as part of that licensable healthcare service; | | (d) | the Minister may approve different approved medical treatments or services under paragraph (c) for different licensable healthcare services; and | | (e) | the Minister need not approve an approved medical treatment or services for the medical institution in respect of every one of its licensable healthcare services. |
|
(5) To avoid doubt, where —| (a) | a medical institution is licensed under the Healthcare Services Act 2020 to provide a licensable healthcare service by 2 or more service delivery modes (called in this section authorised service delivery modes); and | | (b) | the medical institution provides one or more approved medical treatments or services as part of the licensable healthcare service, |
| then, under subsection (2)(a) or (3) — |
| (c) | the Minister may, in respect of any approved medical treatment or services, approve the medical institution for that approved medical treatment or services when provided by any authorised service delivery mode, or only when provided by one or some of those authorised service delivery modes; | | (d) | the Minister may in an approval under paragraph (c) specify different authorised service delivery modes for different approved medical treatments or services; and | | (e) | the Minister need not approve the medical institution for every one of those approved medical treatments or services. |
|
| (6) The Minister may at any time modify a condition of an approval imposed under this section. |
| (7) Where an approved medical institution ceases to be approved under the Healthcare Services Act 2020 to provide a licensable healthcare service by a service delivery mode, the Minister may, without giving the approved medical institution an opportunity to be heard, modify a condition of the approval imposed under this section for the purpose of providing that the approved medical treatment or services must not be provided by that service delivery mode. |
(8) In this section —| “modify”, in relation to a condition of an approval, includes deleting, varying and substituting a condition, and adding a condition; |
| “service delivery mode” has the meaning given by section 2(1) of the Healthcare Services Act 2020. |
|
[Act 40 of 2024 wef 01/04/2025] |
| Revocation or suspension of approval of medical institution in respect of approved medical treatment or services |
3B.—(1) The Minister may revoke an approval granted to a medical institution in respect of any approved medical treatment or services if —| (a) | the approval has been obtained by the medical institution by fraud, or the medical institution has, in connection with the application for the grant of the approval, made a statement or provided any information or document that is false, misleading or inaccurate in a material particular; | | (b) | there is a reasonable likelihood that the medical institution is contravening or not complying with, or has contravened or failed to comply with, a condition of the approval imposed under section 3A, or any provision of this Act; | | (c) | the medical institution is, or is likely to be, declared a bankrupt (if a natural person) or has gone, or is likely to go, into compulsory or voluntary liquidation other than for the purpose of amalgamation or reconstruction; | | (d) | the medical institution has made any assignment to, or composition with, the medical institution’s creditors or is unable to pay its debts; | | (e) | any of the following persons has been convicted, whether in Singapore or elsewhere, of an offence involving fraud or dishonesty, or of an offence the conviction for which involves a finding that the person convicted had acted fraudulently or dishonestly, whether the applicable offence is committed before, on or after the date of commencement of section 4 of the MediShield Life Scheme (Amendment) Act 2024:| (i) | the medical institution; | | (ii) | any key appointment holder, Principal Officer or Clinical Governance Officer of the medical institution; | | (iii) | any medical practitioner employed or engaged by the medical institution to provide any approved medical treatment or services; |
| | (f) | the licence granted to the medical institution under the Healthcare Services Act 2020 authorising the medical institution to provide the licensable healthcare service that the approved medical treatment or services is or is a part of, is revoked or suspended; | | (g) | all of the following conditions are satisfied:| (i) | the medical institution was approved under section 3A in respect of that approved medical treatment or services on the condition that the approved medical treatment or services is provided by certain authorised service delivery modes (as defined in section 3A(5)(a)); | | (ii) | in respect of the licensable healthcare service that the approved medical treatment or services is or is a part of, the medical institution ceases to be approved under the Healthcare Services Act 2020 to provide the licensable healthcare service by every one of those authorised service delivery modes; |
| | (h) | the Minister considers it in the public interest to do so; or | | (i) | any other ground that is prescribed by the Minister is satisfied. |
(2) The Minister may, if the Minister considers it desirable to do so —| (a) | suspend the approval of a medical institution in respect of any approved medical treatment or services for a specified period, instead of revoking the approval under subsection (1); and | | (b) | at any time —| (i) | extend the suspension for a specified period; or | | (ii) | cancel the suspension. |
|
|
| (3) The Minister must not revoke an approval under subsection (1), or suspend an approval under subsection (2), without giving the medical institution concerned written notice of the Minister’s intention to do so and a reasonable opportunity to make representations as to why the approval should not be revoked or suspended. |
(4) Subsection (3) does not apply where the medical institution —| (a) | if a natural person — has died or is adjudged bankrupt; or | | (b) | in any other case — has been dissolved or wound up or has otherwise ceased to exist. |
|
(5) Where any approval of a medical institution for an approved medical treatment or services is revoked or suspended —| (a) | the approved medical treatment or services is not a claimable medical treatment or services in relation to that medical institution where it is provided during the period of suspension or on or after the date of revocation, unless the Minister otherwise permits; but | | (b) | the revocation or suspension does not affect any claim for any such approved medical treatment or services provided before or after the period of suspension, or before the date of revocation. |
|
| (6) Where the Minister revokes or suspends any approval of a medical institution in respect of any approved medical treatment or services under this section, the medical institution must immediately inform all the patients and customers that are or may be provided the licensable healthcare service that the approved medical treatment or services is or is a part of, of the revocation or suspension. |
(7) For the purposes of this section —| (a) | a medical institution that is a company is unable to pay its debts if it is deemed to be unable to pay its debts under section 125(2) of the Insolvency, Restructuring and Dissolution Act 2018; | | (b) | a medical institution that is an unregistered company is unable to pay its debts if it is deemed to be unable to pay its debts under section 246(2) of the Insolvency, Restructuring and Dissolution Act 2018; and | | (c) | a medical institution that is a limited liability partnership is unable to pay its debts if it is deemed to be unable to pay its debts under paragraph 3(2) of the Fifth Schedule to the Limited Liability Partnerships Act 2005. |
|
(8) In this section —| “Clinical Governance Officer”, “key appointment holder” and “Principal Officer” have the meanings given by section 2(1) of the Healthcare Services Act 2020; |
| “company” has the meaning given by section 4(1) of the Companies Act 1967; |
| “limited liability partnership” has the meaning given by section 4(1) of the Limited Liability Partnerships Act 2005; |
| “unregistered company” has the meaning given by section 245 of the Insolvency, Restructuring and Dissolution Act 2018. |
|
[Act 40 of 2024 wef 01/04/2025] |
4.—(1) The premium for each insurance period (called in this section the relevant insurance period) is to be paid —| (a) | not later than 30 days after the beginning of the relevant insurance period, or on or before such later date as the Board may permit; | | (b) | in such manner as the Board may permit; and | | (c) | by all or any of the following persons, and in such proportion, as the Board may require:| (i) | the insured person; | | (ii) | a parent or both parents of the insured person, subject to any provision in the relevant regulations, if the insured person has not attained 21 years of age at the beginning of the relevant insurance period. |
|
[Act 40 of 2024 wef 01/04/2025] | (1A) The premium for each relevant insurance period is the amount specified in a prescribed manner, which may include a website. [Act 40 of 2024 wef 01/04/2025] |
| (1B) For the purposes of subsection (1A), different rates of premiums may be specified for different classes of insured persons. [Act 40 of 2024 wef 01/04/2025] |
(2) Despite anything in the CPF Act, the Board is entitled to deduct, from the amount standing to a person’s credit in that person’s medisave account, the whole or any part of the premium for the relevant insurance period (including any interest or penalty imposed under section 11(1)(a) or 17, as the case may be, in respect of that premium) —| (a) | payable by that person under subsection (1)(c)(i) or (ii); or | | (b) | payable by any other person, in the circumstances prescribed in the relevant regulations. |
|
(3) In subsection (1), “parent”, in relation to an insured person who has not attained 21 years of age, includes —| (a) | an adoptive parent of the insured person; | | (b) | a step-parent of the insured person; or | | (c) | a guardian, or any person who has the actual custody, of the insured person. |
|
|
5.—(1) Where the whole or any part of the premium paid by a person is liable to be refunded under this Act, the amount may be refunded —| (a) | into that person’s account in the Central Provident Fund; or | | (b) | in such other manner as the Board may determine. |
(2) The Board is entitled to recover on behalf of the Government from any amount which is liable to be refunded under this Act —| (a) | any Government grant for the payment of the premium payable for a person’s insurance cover under the Scheme; and | | (b) | any interest which the person is liable to pay the Government under the terms of the Government grant. |
|
(3) Where a person who has paid in cash any sum towards the premium for any insurance period (called in this section the relevant person), whether for the relevant person or for any other person, dies before the start of that insurance period, and the sum does not exceed such amount as the Minister may, by notification in the Gazette, specify —| (a) | the Board may pay to a proper claimant the whole or any part, as the Board may determine, of the sum; and | | (b) | the receipt of the proper claimant is a discharge to the Board for the payment to the proper claimant under paragraph (a). |
|
| (4) Subsection (3) does not affect any recourse which any person may have against a proper claimant for an amount paid to the proper claimant under subsection (3)(a). |
(5) In this section —| “child” means a legitimate child and includes any child adopted by virtue of an order of court under any written law for the time being in force in Singapore, Malaysia or Brunei Darussalam; |
“parent” includes —| (a) | an adoptive parent of the relevant person; | | (b) | a step-parent of the relevant person; or | | (c) | a guardian, or any person who has the actual custody, of the relevant person; |
|
“proper claimant” means a person who —| (a) | claims to be entitled to a sum referred to in subsection (3) on the death of a relevant person, as personal representative of the relevant person; or | | (b) | claims to be entitled (whether for the person’s own benefit or not) to a sum referred to in subsection (3) on the death of a relevant person, and is the widower, widow, child, grandchild, parent, brother, sister, nephew, niece, grandparent, uncle or aunt of the relevant person. |
|
|
|
| Recovery of amounts paid in excess and short payments |
6.—(1) If, on account of any material change in the information available to the Board or the correction of any error, or in any other circumstances prescribed in the relevant regulations, the Board finds that there is any shortfall in any premium paid in respect of any insurance period by or for any person insured or to be insured under the Scheme, the amount of the shortfall is payable, by all or any of the following persons, and in such proportion, as the Board may require:| (a) | a person by whom the premium is payable under section 4(1)(c)(i) or (ii); | | (b) | a person by whom the premium is payable under section 4(2)(b). |
(2) If, on account of any material change in the information available to the Board or the correction of any error, or in any other circumstances prescribed in the relevant regulations, the Board finds that any benefit under the Scheme has been paid in excess of the amount that ought to have been paid under the Scheme, the excess payment is to be repaid to the Fund in accordance with the relevant regulations —| (a) | by the insured person; or | | (b) | if the excess payment has been paid by the Board directly to the credit of an approved medical institution, by that approved medical institution. |
|
(3) The Board may charge an insured person, a person by whom the premium is payable or an approved medical institution an administrative fee prescribed in the relevant regulations, if any material change, error or prescribed circumstances referred to in subsection (1) or (2) arises from incorrect information which is —| (a) | provided by the insured person, the person by whom the premium is payable or the approved medical institution, as the case may be; and | | (b) | included in a health declaration, means declaration or claim application made under the Scheme. |
|
| (4) Sections 4(2), 7(2), 32(2) and 34(2)(e) and Part 3 apply, with such modifications as may be prescribed in the relevant regulations, to any amount payable under this section as they apply to a premium. |
|
7.—(1) The MediShield Fund is renamed the MediShield Life Fund and is to be administered in accordance with this Act.(2) The MediShield Life Fund comprises —| (a) | all premiums (including interest, costs and penalties under sections 11(1)(a), 15(3) and 17, respectively) and any other sums paid under the Scheme; | | (b) | all premiums under the MediShield Scheme paid on or after 1 November 2015; | | (c) | all Government grants paid to the credit of the Fund for the purposes of the Scheme; | | (d) | all gifts or donations given or made by any person for payment into the Fund, or to the Government or the Board for the purposes of the Scheme or for payment into the Fund; | | (e) | all investments out of moneys in the Fund under subsection (5) and the proceeds of any such investments, including the net income from such investments; | | (f) | all composition sums collected under section 24; and | | (g) | all moneys in the MediShield Fund immediately before 1 November 2015. |
|
| (3) All payments under the Scheme are to be met from the Fund. |
| (4) Any costs or expenses incurred in the administration or enforcement of the Scheme may be met from the Fund. |
| (5) The Board may invest the moneys in the Fund in accordance with the standard investment power of statutory boards as defined in section 33A of the Interpretation Act 1965, except that the Board is subject to any general or specific directions from the Minister (instead of the Minister charged with the responsibility for the Board). |
| (6) Every amount paid into or out of the MediShield Fund before 1 November 2015 to defray any costs and expenses incurred for the purposes of the MediShield Scheme or the Scheme is taken to be and always to have been validly paid, and no legal proceedings are to lie or be instituted or maintained in any court of law on account of or in respect of any such payment. |
| (7) The Board is not liable for any payment under the Scheme, or for any costs or expenses incurred in the administration or enforcement of the Scheme, by reason of anything done, purported to be done, or omitted to be done, by the Board in good faith and with reasonable care. |
|
8.—(1) A MediShield Life Council is established, comprising the following members, all of whom are to be appointed by the Minister:| (a) | a Chairperson; | | (b) | a Deputy Chairperson; | | (c) | at least 2 and not more than 15 other individuals. |
(2) In addition to the functions and powers conferred on the Council by other provisions of this Act, the Council also has the following functions:| (a) | to make recommendations to the Minister on policy and scheme parameters to ensure that the Scheme provides effective protection for citizens and permanent residents of Singapore in an affordable and sustainable manner; | | (b) | to review the administration of the Scheme to ensure alignment with the directions of the Council; | | (c) | to advise the Minister on matters related to the investment of the Fund, and any other matters related to the Scheme or the Fund as the Minister may direct. |
|
| (3) The terms and conditions of the appointment of the members of the Council are to be determined by the Minister. |
| (4) The Council may appoint from among its own members or from other persons who are not members such number of committees as the Council thinks fit for purposes which, in the opinion of the Council, would be better managed by means of such committees. |
| (5) Unless otherwise provided by or under this Act, the Council may determine the procedure to be adopted by the Council for the purposes of this Act. |
|
| Delegation of functions and powers |
9.—(1) The Council may in respect of a specified matter or class of matters, by writing, delegate any of its functions, duties or powers under this Act to a member of the Council or a committee appointed under section 8(4), except the power of delegation conferred by this subsection.| (2) The Board may in respect of a specified matter or class of matters, by writing, delegate any of its functions, duties or powers under this Act to a member, an officer or a committee of the Board, except the power of delegation conferred by this subsection. |
| (3) The chief executive officer of the Board may in respect of a specified matter or class of matters, by writing, delegate any of the chief executive officer’s functions, duties or powers under this Act to a member or an officer of the Board, except the power of delegation conferred by this subsection. |
| (4) A recovery body may in respect of a specified matter or class of matters, by writing, delegate any of its powers under this Act to any officer of the recovery body, except the power of delegation conferred by this subsection. |
| (5) Without affecting the power of delegation under section 36 of the Interpretation Act 1965, any Minister who has the power to issue an approval or a direction under Part 5 may in respect of any specified matter or class of matters, by writing, delegate that power to any public officer. |
| (6) Every member, officer, committee or public officer purporting to act pursuant to a delegation under this section is, in the absence of proof to the contrary, presumed to be acting in accordance with the terms of the delegation. |
| (7) A delegation under this section is revocable at will, and no such delegation prevents the exercise of any power, function or duty by the Minister, the Council, the Board, the chief executive officer of the Board or the recovery body (as the case may be) which makes the delegation. |
|
| Nature of rights and benefits under Scheme |
10.—(1) The rights and benefits of an insured person arising from the insured person’s insurance cover under the Scheme are not assignable or transferable.| (2) A policy of insurance issued under the Scheme does not create any legal or equitable trust. |
| (3) Section 73 of the Conveyancing and Law of Property Act 1886 and section 132 of the Insurance Act 1966 do not apply to any policy of insurance issued under the Scheme. |
| (4) The Insurance Act 1966 does not apply to the Scheme or anything done under this Act. |
|
|